TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 96 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,433 | -0.6% | 38 | 0.0% | 0.00% | – |
Q2 2023 | $1,441 | -47.6% | 38 | -66.4% | 0.00% | – |
Q1 2023 | $2,748 | -61.1% | 113 | -53.5% | 0.00% | -100.0% |
Q4 2022 | $7,057 | +41.1% | 243 | +34.3% | 0.00% | 0.0% |
Q3 2022 | $5,000 | +150.0% | 181 | +182.8% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 64 | +45.5% | 0.00% | – |
Q1 2022 | $2,000 | -92.0% | 44 | -91.3% | 0.00% | -100.0% |
Q4 2021 | $25,000 | -37.5% | 506 | -19.4% | 0.00% | -60.0% |
Q3 2021 | $40,000 | -14.9% | 628 | -3.1% | 0.01% | -9.1% |
Q2 2021 | $47,000 | 0.0% | 648 | +0.8% | 0.01% | 0.0% |
Q1 2021 | $47,000 | 0.0% | 643 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $47,000 | +571.4% | 643 | +431.4% | 0.01% | +450.0% |
Q3 2020 | $7,000 | -36.4% | 121 | -26.2% | 0.00% | -33.3% |
Q2 2020 | $11,000 | -42.1% | 164 | -46.9% | 0.00% | -57.1% |
Q1 2020 | $19,000 | +850.0% | 309 | +1445.0% | 0.01% | +600.0% |
Q4 2019 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | – | 20 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
Geduld E E | 8,000 | $1,122,000 | 0.70% |
Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |